KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Long-Term Investments (2016 - 2025)

Eli Lilly's Long-Term Investments history spans 17 years, with the latest figure at $2.8 billion for Q4 2025.

  • For Q4 2025, Long-Term Investments fell 12.87% year-over-year to $2.8 billion; the TTM value through Dec 2025 reached $2.8 billion, down 12.87%, while the annual FY2025 figure was $2.8 billion, 12.87% down from the prior year.
  • Long-Term Investments reached $2.8 billion in Q4 2025 per LLY's latest filing, roughly flat from $2.8 billion in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $3.5 billion in Q2 2021 to a low of $2.6 billion in Q3 2022.
  • Average Long-Term Investments over 5 years is $3.0 billion, with a median of $3.0 billion recorded in 2022.
  • Peak YoY movement for Long-Term Investments: soared 50.44% in 2021, then decreased 25.55% in 2022.
  • A 5-year view of Long-Term Investments shows it stood at $3.2 billion in 2021, then decreased by 9.67% to $2.9 billion in 2022, then grew by 5.18% to $3.1 billion in 2023, then grew by 5.37% to $3.2 billion in 2024, then dropped by 12.87% to $2.8 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Long-Term Investments are $2.8 billion (Q4 2025), $2.8 billion (Q3 2025), and $3.2 billion (Q2 2025).